KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) Return on Equity (2019 - 2025)

Vir Biotechnology's Return on Equity history spans 7 years, with the latest figure at 0.56% for Q4 2025.

  • For Q4 2025, Return on Equity fell 12.0% year-over-year to 0.56%; the TTM value through Dec 2025 reached 0.56%, down 12.0%, while the annual FY2025 figure was 0.46%, 8.0% down from the prior year.
  • Return on Equity for Q4 2025 was 0.56% at Vir Biotechnology, up from 0.57% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.71% in Q1 2022 and bottomed at 0.57% in Q3 2025.
  • The 5-year median for Return on Equity is 0.23% (2023), against an average of 0.1%.
  • The largest annual shift saw Return on Equity soared 83bps in 2022 before it crashed -90bps in 2023.
  • A 5-year view of Return on Equity shows it stood at 0.46% in 2021, then tumbled by -47bps to 0.24% in 2022, then plummeted by -254bps to 0.38% in 2023, then fell by -16bps to 0.44% in 2024, then dropped by -29bps to 0.56% in 2025.
  • Per Business Quant, the three most recent readings for VIR's Return on Equity are 0.56% (Q4 2025), 0.57% (Q3 2025), and 0.55% (Q2 2025).